Browse: Companies | People | Financial Organizations
Home > Companies > Endosense

General Information

Websiteendosense.com
CategoryBioTech
Phone41-22-306-19-60
Email
Employees

Offices

Geneva, CHE
Chemin du Grand-Puits 42
1217 Meyrin
Geneva, CHE

Funding

Tags

Endosense

Endosense is a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias. Granted the CE mark in May 2009, Endosense’s TactiCath® is the first and only force-sensing ablation catheter to give physicians a real-time, objective measure of contact force during the catheter ablation procedure. It has undergone considerable pre-clinical and clinical testing, the results of which have created a solid foundation of evidence supporting the feasibility, safety and value of contact force sensing during catheter ablation.

Milestones

  • Dollar
    Endosense received $36M in Series B funding. (10/27/09)
    Posted 10/28/09 at 3:18am

Videos

Screenshots

Endosense screenshot
Above: Endosense
Uploaded: 10/28/09

Sources

  1. Endosense, SA: Series B $36M (onbiovc.com) [edit]
Edit This Page
Last Edited 10/28/09

Revision History RSS Picture

External Links

Embed Widget

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy